(MedPage Today) — A TV commercial for bempedoic acid/ezetimibe (Nexlizet) was deemed “false or misleading” by the FDA due to claims the drug is the only nonstatin to lower bad cholesterol and reduce the risk of heart attacks.
After a 6-day court…
Source link : https://www.medpagetoday.com/cardiology/generalcardiology/119399
Author :
Publish date : 2026-01-13 19:48:00
Copyright for syndicated content belongs to the linked Source.
